Dopexamine After Heart Surgery: An Uncommonly Used, Though Useful Inotropic Agent

By  

Recent Patents on Cardiovascular Drug Discovery, Vol. 5, Iss. 1, 2010-01 ,pp. : 66-68

Bentham Science Publishers

Access to resources Recommend Favorite

Which patients can be weaned from inotropic support within 24 hours after cardiac surgery?

By Tsukui Hiroyuki   Koh Eisei   Yokoyama Shin’ya   Ogawa Mitsugu  

Heart and Vessels, Vol. 19, Iss. 5, 2004-09 ,pp. : 225-229

Springer Publishing Company

Access to resources Recommend Favorite

Short-duration, single-agent antibiotic prophylaxis for meningitis in trans-sphenoidal surgery

By Little Andrew  

Pituitary, Vol. 14, Iss. 4, 2011-12 ,pp. : 335-339

Springer Publishing Company

Access to resources Recommend Favorite

Molecular mechanism of levosimendan action: an update

By Rosevear P.R.   Finley N.  

Journal of Molecular and Cellular Cardiology, Vol. 35, Iss. 9, 2003-09 ,pp. : 1011-1015

Elsevier

Access to resources Recommend Favorite

The clinical effects of levosimendan are not attenuated by sulfonylureas

By Kivikko Matti   Nieminen Markku S.   Pollesello Piero   Pohjanjousi Pasi   Colucci Wilson S.   Teerlink John R.   Mebazaa Alexandre  

Scandinavian Cardiovascular Journal, Vol. 46, Iss. 6, 2012-12 ,pp. : 330-338

Informa Healthcare

Access to resources Recommend Favorite